Intra-individual genomic diversity between circulating tumor cell-free DNA (cfDNA) and tumor tissue testing in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Hahn, Andrew W.
Gill, David Michael
Streeter, Jessica
Bailey, Erin B.
Carroll, Emma
Aryal, Lubina
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.444
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
444
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Feasibility of cell-free circulating tumor DNA testing for lung cancer
    Santarpia, Mariacarmela
    Karachaliou, Niki
    Gonzalez-Cao, Maria
    Altavilla, Giuseppe
    Giovannetti, Elisa
    Rosell, Rafael
    BIOMARKERS IN MEDICINE, 2016, 10 (04) : 417 - 430
  • [22] Illustration of temporal evolution in patients with metastatic renal cell carcinoma (mRCC) using both circulating tumor DNA (ctDNA) and tissue-based genomic data.
    Zengin, Zeynep Busra
    Weipert, Caroline
    Hsu, Joann
    Salgia, Nicholas
    Hensel, Chuck
    Maughan, Benjamin Louis
    Rathi, Nityam
    Goel, Divyam
    Agarwal, Neeraj
    Choueiri, Toni K.
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [23] Concordance between genomic alterations assessed by next-generation sequencing in tumor tissue or circulating cell-free DNA
    Chae, Young Kwang
    Davis, Andrew A.
    Carneiro, Benedito A.
    Chandra, Sunandana
    Mohindra, Nisha
    Kalyan, Aparna
    Kaplan, Jason
    Matsangou, Maria
    Pai, Sachin
    Costa, Ricardo
    Jovanovic, Borko
    Cristofanilli, Massimo
    Platanias, Leonidas C.
    Giles, Francis J.
    ONCOTARGET, 2016, 7 (40) : 65364 - 65373
  • [24] Gene expression profile of circulating tumor cells (CTCs) in clear cell metastatic renal cell carcinoma (mRCC)
    Iacovelli, R.
    Nicolazzo, C.
    Petracca, A.
    Risi, E.
    Cortesi, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [25] Cell-free circulating tumor DNA (cfDNA) analysis of advanced thymic epithelial tumors (TETs).
    Dada, Hiba I.
    Drusbosky, Leylah
    Giaccone, Giuseppe
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Comparison of circulating tumor cell (CTC) derived DNA and circulating cell-free DNA (cfDNA) from simultaneous blood sampling of patients with metastatic breast cancer (MBC)
    Liu, Minetta C.
    Giridhar, Karthik V.
    Ferre, Roberto A. Leon
    Carroll, Jamie L.
    Goetz, Matthew P.
    Haddad, Tufia C.
    Smith, Deanne R.
    Yadav, Siddhartha
    Kapoor, Vidushi
    Liu, Guoying
    George, Tad
    Ericson, Nolan
    Ramirez, Arturo B.
    Kaldjian, Eric
    Haselkorn, Keegan E.
    CANCER RESEARCH, 2020, 80 (16)
  • [27] Cell-free DNA (cfDNA) fragmentomes predict tumor burden in metastatic colorectal cancer (mCRC).
    Leal, Alessandro
    van 't Erve, Iris
    Lumbard, Keith
    Keefer, Laurel
    Carey, Jacob
    Wu, Tony
    Jakubowski, Debbie
    Butler, Denise
    Rongione, Michael
    Chesnick, Bryan
    Punt, Cornelis J. A.
    Meijer, Gerrit A.
    Dracopoli, Nicholas C.
    Maddala, Tara
    Scharpf, Robert
    Bach, Peter Brian
    Velculescu, Victor E.
    Fijneman, Remond
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Cell-free DNA resuscitated for tumor testing
    Michael Fleischhacker
    Bernd Schmidt
    Nature Medicine, 2008, 14 : 914 - 915
  • [29] Cell-free DNA resuscitated for tumor testing
    Fleischhacker, Michael
    Schmidt, Bernd
    NATURE MEDICINE, 2008, 14 (09) : 914 - 915
  • [30] Erratum to: Comparative clinical utility of tumor genomic testing and cell-free DNA in metastatic breast cancer
    Kara N. Maxwell
    Danielle Soucier-Ernst
    Emin Tahirovic
    Andrea B. Troxel
    Candace Clark
    Michael Feldman
    Christopher Colameco
    Bijal Kakrecha
    Melissa Langer
    David Lieberman
    Jennifer J. D. Morrissette
    Matt R. Paul
    Tien-chi Pan
    Stephanie Yee
    Natalie Shih
    Erica Carpenter
    Lewis A. Chodosh
    Angela DeMichele
    Breast Cancer Research and Treatment, 2017, 164 : 639 - 640
12345